Nai-Bing Gu | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Nai-Bing Gu | Clinical Neuroscience | Best Researcher Award

Dr. Gu Naibing is a distinguished Chief Physician in the Department of Neurology at Xi’an Central Hospital, specializing in neuroimmunology. He has made significant contributions to the understanding of neurological diseases, particularly those related to autoimmune and inflammatory conditions of the nervous system. As a Master’s degree supervisor and an active member of several professional committees, Dr. Gu has established himself as a leader in the fields of neurology and neuroimmunology. His research, clinical expertise, and involvement in medical organizations have earned him recognition and influence in the medical community. His work continues to have a lasting impact on both the treatment of neurological diseases and the education of future healthcare professionals.

Profile

Scopus

 

👨‍⚕️ Early Academic Pursuits

Dr. Gu Naibing embarked on his academic journey with a keen interest in neurology and medicine. After completing his medical degree, he pursued further studies in the specialized field of neurology, which led to the completion of his Master’s degree. Throughout his academic tenure, Dr. Gu consistently demonstrated a strong dedication to advancing his understanding of complex neurological conditions. His early academic endeavors set the foundation for a career focused on improving patient outcomes and advancing scientific knowledge in neuroimmunology.

💼 Professional Endeavors

Dr. Gu Naibing has established himself as a prominent figure in the field of neurology. As a Chief Physician in the Department of Neurology at Xi’an Central Hospital, he plays a vital role in diagnosing and treating a wide range of neurological disorders. Additionally, he serves as a Master’s degree supervisor, contributing to the training and development of the next generation of medical professionals. His professional network includes multiple roles in prestigious committees, such as the Neuroimmunology Professional Committee of the Shaanxi Provincial International Medical Exchange Promotion Association and the Neurology Branch of the Xi’an Medical Association.

🔬 Contributions and Research Focus

Dr. Gu’s research primarily focuses on neuroimmunology, the intersection of the immune system and neurological diseases. His work has advanced understanding in this field, particularly with regard to the mechanisms underlying autoimmune disorders affecting the nervous system. By contributing to a deeper understanding of brain diseases, Dr. Gu’s research has had significant implications for the development of more effective treatments for patients suffering from conditions such as multiple sclerosis, encephalitis, and other neuroinflammatory disorders. His focus on integrating immunological and neurological disciplines has been pivotal in pushing the boundaries of clinical research.

🏆 Accolades and Recognition

Throughout his career, Dr. Gu Naibing has earned several accolades and recognition for his outstanding contributions to the medical field. His involvement in various professional committees highlights his leadership and influence in the realm of neurology and neuroimmunology. As a standing committee member of the Neuroimmunology Group and the Neurology Professional Committee of the Shaanxi Health Care Association, Dr. Gu’s expertise and leadership are regularly sought after. His recognition extends beyond clinical practice, as he is frequently invited to contribute to national and international discussions on neurological care and research.

🌍 Impact and Influence

Dr. Gu Naibing’s influence extends beyond his clinical and research activities. Through his active involvement in professional organizations, he has had a profound impact on the development of neurology and neuroimmunology practices in China. His leadership in committees, particularly within the Shaanxi Medical Communication Association, has helped bridge gaps between medical professionals, facilitating the exchange of ideas and research findings. His dedication to fostering collaboration among medical communities has contributed to the enhancement of healthcare practices and the overall improvement of patient care.

🧠 Legacy and Future Contributions

As Dr. Gu Naibing continues his work, his legacy in the fields of neurology and neuroimmunology will undoubtedly inspire future generations of healthcare professionals. His commitment to advancing both clinical and research practices ensures that his contributions will have a lasting impact on the treatment of neurological diseases. Looking ahead, Dr. Gu is poised to continue making significant strides in neuroimmunology, with ongoing research and collaborations aimed at developing new therapeutic approaches. His future contributions promise to further shape the landscape of neurological healthcare, enhancing the lives of patients around the world.

🌟 Final Thoughts

Dr. Gu Naibing’s career has been defined by his passion for neurology, his commitment to advancing research, and his tireless efforts to improve patient outcomes. As a clinician, educator, and researcher, he has earned the respect and admiration of his peers, contributing significantly to the advancement of medical knowledge and patient care. With his continued dedication to the field, Dr. Gu’s legacy is sure to endure, influencing both the scientific community and the generations of healthcare professionals who follow in his footsteps.

Publication

  • Title: Effect of BMSCs overexpressing intelectin-1 on angiogenesis in rats with cerebral infarction
    Authors: B. Zhu, K. Guo, L. Zha, L. Chang, N. Gu
    Year: 2025

 

  • Title: Salivary duct carcinoma presenting with unilateral multiple cranial nerve lesions and concurrent intracranial metastasis: A case report
    Authors: B. Zhu, Q. Zhang, K. Guo, Y. Yang, X. Jia
    Year: 2025

 

Conclusion

Dr. Gu Naibing’s career is a testament to his dedication to advancing the field of neurology and neuroimmunology. His groundbreaking research, leadership in medical committees, and commitment to education have shaped the future of neurological care in China. With his continued focus on improving patient care and expanding scientific knowledge, Dr. Gu is poised to make lasting contributions that will positively impact both the medical field and the lives of countless patients. His legacy will inspire future generations of researchers and clinicians in the realm of neurology.

 

Soumya Pahari | Clinical Neuroscience | Young Researcher Award

Published on by Neuroscientists

Dr. Soumya Pahari | Clinical Neuroscience | Young Researcher Award

Dr. Soumya Pahari,  Nepalese Army Institute of Health Sciences, Nepal.

Dr. Soumya Pahari, MBBS, is a globally engaged physician with a deep-rooted passion for neurosurgery, clinical research, and public health advocacy. From excelling in medical school on a full academic scholarship to completing hands-on neurosurgical training in both Nepal and the U.S., Dr. Pahari has built a career that blends clinical excellence with scholarly rigor. Their dedication to global neurosurgical research, reflected through projects with Vanderbilt University and Mission Brain Foundation, demonstrates a commitment to solving complex medical challenges through evidence-based innovation. Beyond the operating theater, their work as a mental health advocate and educator underscores a holistic approach to medicine that prioritizes human connection, education, and equity.

 

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Dr. Soumya Pahari’s academic journey began with a strong foundation in science, nurtured during their high school years at St. Xavier’s College, Nepal,  Their passion for medicine soon led them to pursue an MBBS degree at the Nepalese Army Institute of Health Sciences (NAIHS), where they not only excelled academically but also earned the prestigious NAIHS Academic Scholarship in 2016. Throughout medical school, they developed a keen interest in neuroscience and surgical disciplines, which laid the groundwork for their future specialization in neurosurgery and global neurosurgical initiatives.

🧠 Professional Endeavors in Neurosurgery

Driven by an unrelenting commitment to clinical excellence, Dr. Pahari’s professional training includes a year-long position as House Officer in the Department of Neurosurgery at Shree Birendra Hospital, Nepal’s only neurosurgical unit under the Nepalese Army. Here, they performed critical procedures such as EVD insertion, burr hole evacuation, and tracheostomy, while actively assisting in advanced surgeries like aneurysm clipping and tumor resections. Later, as a Visiting Scholar in Neurosurgery at West Virginia University (WV, USA) under Dr. P. David Adelson, they broadened their exposure by shadowing surgeons, presenting clinical cases, and initiating a quality improvement project focused on vagal nerve stimulators for refractory epilepsy patients. These experiences have collectively enriched Dr. Pahari’s surgical acumen and global neurosurgical insight.

🔬 Contributions and Research Focus

Research forms a core pillar of Dr. Pahari’s career, with a focus on pediatric cerebrovascular disorders, endovascular interventions in extradural hematomas, and quality improvement in epilepsy care. As a Research Collaborator with Vanderbilt Global Neurosurgery Program, they are leading a systematic review to assess the global burden of pediatric cerebrovascular diseases, contributing meaningfully to evidence-based global neurosurgical strategies. Simultaneously, their work with the Mission Brain Foundation aims to analyze the emerging utility of endovascular techniques in traumatic brain injury management. Earlier, they also contributed as an administrator and content developer at the Abdulrauf University of Neurosurgery’s Research Institute in California, helping curate educational content for aspiring neurosurgeon-scientists.

🌍 Advocacy, Mental Health & Global Impact

Dr. Pahari’s commitment to health extends beyond the operating room into the domain of mental health and psychosocial well-being. As a Founding Board Member of Antardhoni Nepal, they’ve played a vital role in promoting mental health awareness and support services in underserved communities. Their leadership also reflects through media engagement as a Podcast Host for ‘Behind White Coats’, a platform where pressing global health issues and common illnesses are discussed with clarity and compassion. These endeavors underline their belief in a holistic approach to health, where mental, social, and physical well-being are equally prioritized.

🏆 Accolades and Recognition

Throughout their academic and professional career, Dr. Pahari has garnered several accolades, notably being ECFMG Certified in August 2024 and scoring an impressive 253 on USMLE Step 2. Their achievements are further supported by certifications such as the Diploma in Neurotrauma Care from the Global Neuro Foundation, which granted them 43.5 AMA PRA Category 1 credits, enhancing their preparedness for managing acute neurotrauma in global contexts. These recognitions reflect their unwavering commitment to clinical excellence and continuous learning.

📢 Influence Through Education and Media

An inspiring communicator and educator, Dr. Pahari has invested time in peer tutoring through Medlife Stories, where they guided junior students through complex medical concepts. Their innovative spirit also led them to head marketing strategies for The SET Exhibition during their early college years—an event that showcased student innovation in science and technology. Through educational content creation, public speaking, and mentoring, Dr. Pahari continues to shape the next generation of healthcare leaders while making medicine more accessible and engaging for all.

🚀 Legacy and Future Contributions

As Dr. Soumya Pahari looks ahead, their vision is clearly anchored in the intersection of clinical neurosurgery, global health equity, and academic research. With ongoing collaborations in global neurosurgical research and growing experience in both developed and developing healthcare systems, they are uniquely positioned to bridge disparities in neurosurgical care. Their future contributions are expected to amplify the voices of underrepresented populations in global health discourse, enhance neurosurgical systems through data-driven quality improvement, and inspire young physicians to approach medicine with both empathy and rigor. Their legacy, still unfolding, promises to be one of profound impact, innovation, and inclusion.

Publication

 

  • Title: Gallstone among patients presenting to the department of surgery in a tertiary care center: a descriptive cross-sectional study
    Authors: S Pahari, S Basukala, U Piya, Y Khand, B Thapa, O Thapa, S Thapa
    Year: 2023

 

  • Title: A rare case of retroperitoneal extension in Fournier’s gangrene: A case report and review of literature
    Authors: S Basukala, Y Khand, S Pahari, KB Shah, A Shah
    Year: 2022

 

  • Title: Large posterior mediastinal ganglioneuroma with intradural cervical spine extension: a rare case report and review of literature
    Authors: A Dahal, JJ Malla, D Neupane, N Lageju, LS Jaiswal, S Chaudhary, …
    Year: 2022

 

  • Title: Complicated pylephlebitis secondary to perforated appendicitis in a child-A rare case report
    Authors: S Pahari, M Shrestha, S Basukala, P Kafle, K Rai, Y Khand, O Thapa, …
    Year: 2022

 

  • Title: A life-threatening complication of biliary peritonitis following T-tube removal: A case report and review of literature
    Authors: Y Khand, S Basukala, U Piya, P Mainali, S Pahari, KB Shah
    Year: 2022

 

  • Title: Spontaneous splenic hematoma secondary to dengue infection: a rare case report
    Authors: S Pahari, S Basukala, P Kunwar, K Thapa, Y Khand, O Thapa
    Year: 2023

 

  • Title: An unusual case of perforated stump appendicitis: a case report
    Authors: S Basukala, BD Pathak, S Pahari, S Gurung, B Basukala, BB Rayamajhi, …
    Year: 2022

 

  • Title: Acute Pancreatitis among Patients Visiting the Department of Surgery in a Tertiary Care Centre: A Descriptive Cross-sectional Study
    Authors: S Basukala, BD Pathak, P Dawadi, S Bohara, A Tamang, S Pahari, …
    Year: 2023

 

  • Title: Patient Safety and organizational Safety Culture in Surgery: A Need of an Hour in the developing countries
    Authors: S Basukala, S Bohara, A Thapa, A Shah, S Pahari, Y Khand, O Thapa, …
    Year: 2022

 

  • Title: Acute recurrent pancreatitis in a child with pancreatic divisum–A case report
    Authors: O Thapa, S Basukala, M Shrestha, Y Khand, S Pahari, S Bohara, A Thapa, …
    Year: 2022

 

✅ Conclusion

With a powerful blend of academic distinction, surgical skill, and compassionate advocacy, Dr. Soumya Pahari stands at the forefront of a new generation of physician-leaders. Their journey is a testament to the impact that global collaboration, research, and empathy can have on healthcare. As they continue to pursue excellence in neurosurgery and global health, their work promises not only to improve lives in the operating room but to inspire systemic change across borders. The future undoubtedly holds even greater contributions from this rising medical changemaker.

Camilla Bellone | Translational Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Camilla Bellone | Translational Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Camilla Bellone,  University of Geneva, Switzerland.

Dr. Camilla Bellone is a renowned neuroscientist whose academic and research career has been marked by excellence, innovation, and impact. From her foundational training in Italy to her leadership role in Geneva, she has made pioneering contributions to understanding the neural underpinnings of social behavior. Her work bridges basic science and clinical relevance, and she has played a vital role in training, mentorship, and international collaboration within the neuroscience community.

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Dr. Camilla Bellone began her academic journey with a Master’s degree in Pharmacy from the University of Milano in 2000. With a strong foundation in pharmacology and medical chemistry, she pursued her Ph.D. in “Pharmacology, Toxicology, and Medical Chemotherapy” at the same institution, completing it in 2006. Her early education shaped a robust scientific mindset, preparing her for a career at the intersection of neuroscience and pharmacology. These formative years set the tone for her later work on the molecular mechanisms that govern complex behaviors in both healthy and diseased states.

🧪 Professional Endeavors

After her doctoral studies, Dr. Bellone enhanced her research acumen through a postdoctoral fellowship at the University of California, San Francisco (UCSF), gaining international exposure. She later returned to Switzerland, where she served as a scientist under the Ambizione Fellowship at the University of Geneva. Her academic path took a significant leap when she became an Assistant Professor at the University of Lausanne in 2014, followed by a transition to the University of Geneva in 2016. In 2020, she was promoted to Associate Professor in the Department of Basic Neuroscience, where she continues to lead cutting-edge investigations and mentor future neuroscientists.

🧠 Contributions and Research Focus

At the core of Dr. Bellone’s research lies a deep interest in the neurobiological basis of social behavior, with a particular focus on how these processes are disrupted in neuropsychiatric disorders. Her lab explores the synaptic and circuit-level mechanisms that underpin social cognition, often using advanced molecular and behavioral techniques. Her work has provided critical insights into how alterations in neural plasticity and connectivity contribute to diseases such as schizophrenia and autism spectrum disorders. With over 40 peer-reviewed publications in high-impact journals like Nature Neuroscience and Neuron, Dr. Bellone’s research continues to advance the field of behavioral neuroscience.

🏆 Accolades and Recognition

Dr. Bellone’s scientific excellence has been recognized through several prestigious honors. In 2023, she received the EBBS Mid-Career Award and the Leenaards Scientific Prize for her collaborative project on cerebellar stimulation in schizophrenia. Earlier, she was elected to the distinguished FENS-KAVLI Network of Excellence in 2015, highlighting her position among Europe’s most promising neuroscientists. In 2014, she was honored with the Fondation du Prix Pfizer de la Recherche, marking an early milestone in her independent research career.

🌍 Impact and Influence

Beyond her lab, Dr. Bellone has made meaningful contributions to the academic and scientific community. She has delivered over 20 invited lectures at international conferences and institutions, sharing her discoveries with a global audience. As a dedicated mentor, she has guided eight master’s students and seven PhD candidates, nurturing the next generation of neuroscientists. Her commitment extends to active service on academic committees, grant review panels, and editorial boards, reflecting her role as a respected leader in the field.

👩‍🔬 Balancing Science and Life

A champion of work-life integration, Dr. Bellone has managed to thrive professionally while embracing motherhood. She took two career breaks following the birth of her three children, exemplifying resilience and balance in a demanding academic landscape. Her story is an inspiration to young scientists, especially women, striving to build careers in STEM while honoring personal life choices.

🔬 Legacy and Future Contributions

Looking ahead, Dr. Bellone’s work holds promise for transforming our understanding of social dysfunction in mental illness. Her innovative approaches—blending circuit neuroscience, pharmacology, and behavior—position her as a leading voice in the neurobiology of social behavior. With continued support from initiatives like the ERC Consolidator Grant, her research will likely pave the way for novel therapeutic interventions, leaving a lasting legacy in neuroscience and psychiatry.

Publication

  • Title: NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
    Author: P Paoletti, C Bellone, Q Zhou
    Year: 2013

 

  • Title: Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression
    Author: C Bellone, C Lüscher
    Year: 2006

 

  • Title: Rapid bidirectional switching of synaptic NMDA receptors
    Author: C Bellone, RA Nicoll
    Year: 2007

 

  • Title: Cocaine inverts rules for synaptic plasticity of glutamate transmission in the ventral tegmental area
    Author: M Mameli, C Bellone, MTC Brown, C Lüscher
    Year: 2011

 

  • Title: In vivo reprogramming of circuit connectivity in postmitotic neocortical neurons
    Author: A De la Rossa, C Bellone, B Golding, I Vitali, J Moss, N Toni, C Lüscher, …
    Year: 2013

 

  • Title: Mechanisms of synaptic depression triggered by metabotropic glutamate receptors
    Author: C Bellone, C Lüscher, M Mameli
    Year: 2008

 

  • Title: Effects of streptozotocin‐diabetes on the hippocampal NMDA receptor complex in rats
    Author: F Gardoni, A Kamal, C Bellone, GJ Biessels, GMJ Ramakers, F Cattabeni, …
    Year: 2002

 

  • Title: Neurons under T cell attack coordinate phagocyte-mediated synaptic stripping
    Author: G Di Liberto, S Pantelyushin, M Kreutzfeldt, N Page, S Musardo, R Coras, …
    Year: 2018

 

  • Title: mGluRs induce a long‐term depression in the ventral tegmental area that involves a switch of the subunit composition of AMPA receptors
    Author: C Bellone, C Lüscher
    Year: 2005

 

  • Title: SHANK3 controls maturation of social reward circuits in the VTA
    Author: S Bariselli, S Tzanoulinou, C Glangetas, C Prévost-Solié, L Pucci, …
    Year: 2016

 

✅ Conclusion

Dr. Bellone’s journey reflects a remarkable blend of scientific curiosity, academic leadership, and personal resilience. As she continues to explore the brain’s most intricate social circuits, her influence will undoubtedly expand across neuroscience, psychiatry, and therapeutic innovation. Her career serves as both a roadmap and an inspiration for emerging scientists navigating the evolving landscape of brain research.

 

Kiran Solingapuram Sai | Neuroimaging | Best Researcher Award

Published on by Neuroscientists

Dr. Kiran Solingapuram Sai | Neuroimaging | Best Researcher Award

Dr. Kiran Solingapuram Sai, Wake Forest School of Medicine, United States.

Dr. Kiran K. Solingapuram Sai, PhD, is an Associate Professor with tenure in the Department of Radiology at Wake Forest School of Medicine. He holds a Ph.D. in Organic Chemistry from Northern Illinois University and has extensive research experience in radiopharmaceutical chemistry. His postdoctoral training at Washington University’s Mallinckrodt Institute of Radiology focused on radiotracer development.

Profile

Orcid

 

✨ Early Academic Pursuits

Dr. Kiran K. Solingapuram Sai embarked on his academic journey with a strong foundation in chemistry, earning a Bachelor of Science degree in Chemistry, Biochemistry, and Microbiology from Osmania University, Hyderabad, India, in 2001. His passion for organic chemistry led him to pursue a Master of Science in the same field at Osmania University, where he honed his expertise in chemical synthesis and molecular interactions. Determined to explore the depths of organic chemistry, he pursued his Ph.D. at Northern Illinois University, DeKalb, IL, under the mentorship of Dr. Douglas A. Klumpp. During this period, his research focused on synthetic methodologies and organic reaction mechanisms, paving the way for his future contributions to medicinal and radiopharmaceutical chemistry.

🌐 Professional Endeavors

Dr. Sai’s professional journey commenced with a prestigious postdoctoral research associate position at the Mallinckrodt Institute of Radiology at Washington University in St. Louis, MO, where he worked under the guidance of Dr. Robert H. Mach. During his tenure from 2010 to 2013, he delved into the complexities of radiochemistry, developing novel radiotracers and exploring their applications in medical imaging. This experience laid the groundwork for his career in radiopharmaceutical sciences. In 2014, he joined Wake Forest School of Medicine as a Research Instructor and Chief Radiochemist, marking the beginning of his significant contributions to translational imaging and radiopharmaceutical production.

⚛️ Contributions and Research Focus

At Wake Forest School of Medicine, Dr. Sai played a pivotal role in the Department of Radiology and the Clinical Translational Science Institute (CTSI). He specialized in managing clinical and research-based radiopharmaceutical production at the Wake Forest PET Research Center. As a cyclotron manager and coordinator, he oversaw the synthesis and quality control of radiotracers essential for PET imaging. His expertise extended to the development and implementation of cGMP-approved protocols for C-11 and F-18 radiopharmaceutical production, ensuring the highest standards of safety and efficacy. His research focuses on advancing PET imaging techniques, exploring new radiotracers for diagnostic and therapeutic applications, and improving imaging biomarker development.

🏆 Accolades and Recognition

Dr. Sai’s dedication to radiochemistry and molecular imaging has earned him recognition in the scientific community. His work has been instrumental in developing radiopharmaceuticals for neurological and oncological imaging, contributing significantly to early disease detection and targeted therapy. His contributions have been acknowledged through numerous research grants, collaborative projects, and publications in high-impact scientific journals. His commitment to excellence and innovation has positioned him as a leading figure in the field of radiopharmaceutical sciences.

🔬 Impact and Influence

Beyond his research and technical expertise, Dr. Sai has mentored budding scientists and researchers in the field of radiochemistry and imaging sciences. His guidance has helped shape the next generation of radiopharmaceutical experts, fostering a culture of innovation and scientific curiosity. His role in translational imaging programs has bridged the gap between basic research and clinical applications, directly impacting patient care by improving diagnostic imaging techniques.

💡 Legacy and Future Contributions

Dr. Sai’s work continues to inspire advancements in molecular imaging and radiopharmaceutical development. As an Associate Professor with tenure at Wake Forest School of Medicine, he remains dedicated to pushing the boundaries of radiochemistry, developing cutting-edge imaging agents, and enhancing the precision of diagnostic medicine. His legacy in the field is defined by his unwavering commitment to scientific discovery, translational research, and the continuous pursuit of excellence in radiopharmaceutical sciences.Dr. Kiran K. Solingapuram Sai’s contributions to the field of radiopharmaceutical chemistry stand as a testament to his dedication, innovation, and impact on medical imaging and healthcare. His journey from a passionate chemistry student to a distinguished professor and researcher highlights the transformative power of science in shaping the future of medicine.

 

Publication

  1. Radiation-induced brain injury in non-human primates: A dual tracer PET study with [11C]MPC-6827 and [11C]PiB

    • Authors: Naresh Damuka, George W. Schaaf, Mack Miller, Caleb Bradley, Bhuvanachandra Bhoopal, Ivan Krizan, Krishna K. Gollapelli, Christopher T. Whitlow, J. Mark Cline, Kiran K. Solingapuram Sai
    • Year: 2025

 

  1. The β-Secretase 1 Enzyme as a Novel Therapeutic Target for Prostate Cancer

    • Authors: Hilal A. Rather, Sameh Almousa, Ashish Kumar, Mitu Sharma, Isabel Pennington, Susy Kim, Yixin Su, Yangen He, Abdollah R. Ghara, Kiran Kumar Solingapuram Sai et al.
    • Year: 2023

 

  1. Development and Optimization of 11C-Labeled Radiotracers: A Review of the Modern Quality Control Design Process

    • Authors: Paul Josef Myburgh, Kiran Kumar Solingapuram Sai
    • Year: 2023

 

  1. Binding Parameters of [11C]MPC-6827, a Microtubule-Imaging PET Radiopharmaceutical in Rodents

    • Authors: Avinash H. Bansode, Bhuvanachandra Bhoopal, Krishna Kumar Gollapelli, Naresh Damuka, Ivan Krizan, Mack Miller, Suzanne Craft, Akiva Mintz, Kiran Kumar Solingapuram Sai
    • Year: 2023

 

  1. PET Imaging of [11C]MPC-6827, a Microtubule-Based Radiotracer in Non-Human Primate Brains

    • Authors: Naresh Damuka, Paul W. Czoty, Ashley T. Davis, Michael Nader, Susan H. Nader, Suzanne Craft, Shannon L. Macauley, Lindsey K. Galbo Thomma, Phillip M. Epperly, Christopher T. Whitlow et al.
    • Year: 2020

 

  1. One-pot synthesis of novel tert-butyl-4-substituted phenyl-1H-1,2,3-triazolo piperazine/piperidine carboxylates, potential GPR119 agonists

    • Authors: Nagaraju Bashetti, J.V. Shanmukha Kumar, Naresh Varma Seelam, B. Prasanna, Akiva Mintz, Naresh Damuka, Sriram Devanathan, Kiran Kumar Solingapuram Sai
    • Year: 2019

 

Conclusion

Dr. Kiran K. Solingapuram Sai has established himself as a leading expert in radiopharmaceutical sciences, contributing significantly to translational imaging research. His work in PET radiopharmaceutical production and quality assurance underscores his role in advancing medical imaging techniques. His academic and research contributions make him a valuable asset in the field of radiology and molecular imaging.

John Vincent Sanchez Orti | Biomarkers in Neurocognition | Young Scientist Award

Published on by Neuroscientists

Dr. John Vincent Sanchez Orti | Biomarkers in Neurocognition | Young Scientist Award

Dr. Joan Vicent Sánchez Ortí, Health research institute,  Spain.

Joan Vicent Sánchez Ortí is a Clinical Psychologist and Neuropsychologist currently working as a Research Technician at the Instituto de Investigación Sanitaria – INCLIVA. He is also a predoctoral researcher affiliated with CIBERSAM (Group 24, Universitat de València). His academic background includes a Bachelor’s degree in Psychology (2016), a Master’s in General Health Psychology (2019), and a Master’s in Basic and Applied Neurosciences (2021), all from Universitat de València. He is currently pursuing a Ph.D. in Medicine.

Profile

Google Scholar

Orcid

🧠 A Passion for Understanding the Mind

Joan Vicent Sánchez Ortí was born on August 6, 1994, with an innate curiosity about the complexities of human cognition. From an early age, he displayed a deep interest in psychology and neuroscience, which led him to pursue an academic path dedicated to unraveling the mysteries of the brain. His journey began at the Universitat de València, where he obtained his degree in Psychology in 2016. Motivated by his growing fascination with neuropsychology, he continued his studies, earning a Master’s in General Health Psychology in 2019 and a Master’s in Basic and Applied Neurosciences in 2021. His dedication to advancing medical science led him to enroll in an official Doctorate Program in Medicine at the same institution.

🏥 Bridging Psychology and Neuroscience in Professional Practice

Currently serving as a Neuropsychologist and Research Technician at the Health Research Institute (INCLIVA) in Spain, Joan Vicent plays a vital role in understanding cognitive impairments associated with severe mental disorders. His affiliation with the Biomedical Research Center in Mental Health Network (CIBERSAM) – Group 24 at the Universitat de València has allowed him to contribute significantly to groundbreaking studies. His expertise lies in assessing neurocognitive deficits, biomarkers, and epigenetic factors, aiming to enhance the diagnosis and treatment of psychiatric and neurological conditions.

🔬 Advancing Research in Neurocognitive Deficits and Mental Health

Joan Vicent’s research delves into the intricate connections between brain function, cognition, and mental health. His studies focus on identifying early biomarkers of cognitive decline, exploring epigenetic influences, and evaluating social functioning and quality of life in patients suffering from severe mental disorders. His contributions have been instrumental in improving the understanding of conditions such as schizophrenia, bipolar disorder, and neurodegenerative diseases, providing valuable insights for clinical interventions.

🏆 Recognized for Excellence in Neuroscience and Psychology

Through his commitment to scientific discovery, Joan Vicent has garnered recognition in the field of neuroscience and psychology. His contributions to neuropsychology and mental health research have positioned him as a promising figure in cognitive science. His work is widely acknowledged for its impact on the development of new therapeutic approaches and diagnostic techniques. With a strong academic and research background, he continues to be an influential voice in the study of cognitive impairment.

🌍 Impacting Lives Through Mental Health Research

Beyond academic achievements, Joan Vicent’s work has real-world implications, improving the quality of life for individuals facing cognitive challenges. His research contributes to developing more effective treatments, enhancing diagnostic accuracy, and fostering a better understanding of mental disorders. Through his role at INCLIVA and CIBERSAM, he actively collaborates with interdisciplinary teams, ensuring that his findings are translated into clinical practice, ultimately benefiting patients and healthcare professionals alike.

🚀 Paving the Way for Future Innovations in Neuropsychology

With a strong foundation in psychology, neuroscience, and medicine, Joan Vicent remains dedicated to pushing the boundaries of cognitive research. His ongoing studies aim to integrate cutting-edge techniques in neuroimaging, genetics, and artificial intelligence to refine the understanding of neurocognitive disorders. His ambition is to contribute to the development of personalized medicine, where treatments are tailored to an individual’s neurobiological and psychological profile, revolutionizing mental healthcare.

🔮 A Vision for a Healthier, Cognitively Resilient Future

Looking ahead, Joan Vicent Sánchez Ortí envisions a world where mental health is better understood, diagnosed, and treated with precision. His dedication to neuropsychology and cognitive research will continue to shape the future of mental healthcare, inspiring new generations of scientists and clinicians. As he advances in his career, his unwavering commitment to improving lives through research stands as a testament to his passion and perseverance in the field of neuroscience.

Publication

  • Manual motor speed dysfunction as a neurocognitive endophenotype in euthymic bipolar disorder patients and their healthy relatives. Evidence from a 5-year follow-up study
    P Correa-Ghisays, V Balanzá-Martínez, G Selva-Vera, J Vila-Francés, …
    2017

 

  • Grip Strength, Neurocognition, and social functioning in people With Type-2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia
    M Aliño-Dies, JV Sanchez-Orti, P Correa-Ghisays, V Balanzá-Martinez, …
    2020

 

  • Visual memory dysfunction as a neurocognitive endophenotype in bipolar disorder patients and their unaffected relatives. Evidence from a 5-year follow-up Valencia study
    P Correa-Ghisays, JV Sánchez-Ortí, R Ayesa-Arriola, E Setién-Suero, …
    2019

 

  • Specific metabolic syndrome components predict cognition and social functioning in people with type 2 diabetes mellitus and severe mental disorders
    JV Sanchez‐Orti, V Balanzá‐Martinez, P Correa‐Ghisays, G Selva‐Vera, …
    2022

 

  • Immune–Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and …
    M Garés-Caballer, JV Sánchez-Ortí, P Correa-Ghisays, …
    2022

 

  • Probiotic, prebiotic, synbiotic and fermented food supplementation in psychiatric disorders: A systematic review of clinical trials
    C Ribera, JV Sánchez-Ortí, G Clarke, W Marx, S Mörkl, …
    2024

 

  • Transdiagnostic neurocognitive deficits in patients with type 2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia: A 1-year follow-up study
    P Correa-Ghisays, JV Sanchez-Orti, V Balanza-Martinez, G Selva-Vera, …
    2022

 

  • Inflammation and lipid metabolism as potential biomarkers of memory impairment across type 2 diabetes mellitus and severe mental disorders
    JV Sanchez-Orti, P Correa-Ghisays, V Balanza-Martinez, G Selva-Vera, …
    2023

 

  • MICEmi: A method to identify cognitive endophenotypes of mental illnesses
    P Correa-Ghisays, JV Sanchez-Orti, V Balanza-Martinez, I Fuentes-Dura, …
    2022

 

  • Specific immune-inflammatory profiles and neurocognitive deficits predict illness trajectories in people with type 2 diabetes mellitus or psychiatric disorders
    JV Sanchez-Orti, P Correa-Ghisays, V Balanza-Martinez, G Selva-Vera, …
    2025

 

Conclusion 🎯

Joan Vicent Sánchez Ortí’s dedication to neuroscience and mental health research positions him as an influential figure in the field. His expertise bridges psychology, medicine, and genetics, offering innovative solutions for cognitive disorders. With a strong commitment to improving lives through research, his work has already made a meaningful impact and will continue to shape the future of mental healthcare, neuropsychology, and personalized medicine. As he advances in his career, his passion and contributions will undoubtedly lead to groundbreaking discoveries in cognitive science.

Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo, Xiangya Hospital, Central South University, China.

Dr. Shilin Luo is a leading expert in neuropharmacology and medicinal chemistry, with a strong academic background in traditional Chinese medicine and modern pharmacology. His research focuses on the pathogenesis of neurodegenerative diseases and the development of innovative drug therapies. Through his work at Xiangya Hospital, Central South University, and previous research at Emory University, he has made significant contributions to understanding neurological disorders. His studies on animal models and risk genes have paved the way for novel treatment strategies, earning him international recognition.

Profile

Scopus

Orcid

 

🎓 Early Academic Pursuits

Dr. Shilin Luo’s journey into the world of medical science began with a deep-rooted passion for understanding the complexities of neurological diseases. He earned his Bachelor’s degree in Chinese Materia Medica from Shenyang Pharmaceutical University, where he developed a strong foundation in traditional Chinese medicine and pharmacology. With an insatiable thirst for knowledge, he further pursued a Ph.D. in Medicinal Chemistry at China Pharmaceutical University, specializing in the research of active ingredients in natural products. Under the mentorship of Prof. Wencai Ye, a distinguished scholar, Dr. Luo honed his expertise in medicinal chemistry, paving the way for groundbreaking discoveries in neuropharmacology.

👨‍🎓 Professional Endeavors

To deepen his expertise, Dr. Luo embarked on postdoctoral research at Emory University’s School of Medicine in the Department of Pathology and Laboratory Medicine. Working under the esteemed Prof. Keqiang Ye, he focused on neurobiology and neuropharmacology, contributing significantly to the understanding of neurodegenerative diseases. His research provided novel insights into the molecular mechanisms underlying neurological disorders, positioning him as a leading figure in the field. He later took on a pivotal role as a professor in the Department of Neurology at Xiangya Hospital, Central South University, where he continues to mentor young scientists and advance medical research.

🧪 Contributions and Research Focus

Dr. Luo’s research is primarily dedicated to uncovering the pathogenesis of neurodegenerative diseases and developing therapeutic interventions. His work in animal models of pathogenic and risk genes for neurological disorders has been instrumental in identifying potential drug targets. By integrating traditional Chinese medicine with modern pharmacology, he has contributed to the development of innovative neuroprotective agents. His studies on the molecular mechanisms of neuronal degeneration have led to promising advancements in combating conditions such as Alzheimer’s and Parkinson’s disease.

🏆 Accolades and Recognition

Throughout his career, Dr. Luo has been widely recognized for his groundbreaking contributions to neuropharmacology. His research has been published in high-impact scientific journals, earning him international acclaim. His dedication to scientific excellence has garnered prestigious awards, and he is frequently invited to deliver keynote lectures at global conferences. His work continues to inspire fellow researchers, solidifying his reputation as a distinguished scientist in neurological drug development.

🏰 Impact and Influence

Dr. Luo’s impact extends beyond the laboratory, as he actively contributes to the medical community through mentorship and collaboration. His efforts in integrating traditional Chinese medicinal principles with cutting-edge pharmacological approaches have opened new avenues for drug discovery. His research findings have not only influenced academic discourse but have also laid the groundwork for potential clinical applications, bringing hope to patients suffering from neurodegenerative diseases.

⚛️ Legacy and Future Contributions

As a visionary scientist, Dr. Luo continues to push the boundaries of neurological research. His commitment to translational medicine aims to bridge the gap between laboratory discoveries and clinical applications. By fostering interdisciplinary collaborations and mentoring the next generation of researchers, he is shaping the future of neuropharmacology.

 

Publication

  • Disease-modifying therapies for Alzheimer’s disease: Clinical trial progress and opportunity
    Authors: Yujie Zhang, Jie Chen, Yanru Li, Bin Jiao, Shilin Luo
    Year: 2025

 

  • The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential
    Authors: Ruiling Xu, Yuxuan Zhang, Shurui Chen, Yaohui Zeng, Xuan Fu, Ti Chen, Shilin Luo, Xiaojie Zhang
    Year: 2023

 

  • Nonviral delivery systems for antisense oligonucleotide therapeutics
    Authors: Si Huang, Xin-Yan Hao, Yong-Jiang Li, Jun‑Yong Wu, Da-Xiong Xiang, Shilin Luo
    Year: 2022

 

  • The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid‐β by microglia
    Authors: Si Huang, Xiaoli Liao, Junyong Wu, Xiaojie Zhang, Yamin Li, Daxiong Xiang, Shilin Luo
    Year: 2022

 

  • Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
    Authors: Not explicitly listed
    Year: 2021

 

  • Polygonatum sibiricum Polysaccharides Protect against MPP‐Induced Neurotoxicity via the Akt/mTOR and Nrf2 Pathways
    Authors: Si Huang, Haiyan Yuan, Wenqun Li, Xinyi Liu, Xiaojie Zhang, Daxiong Xiang, Shilin Luo, Guodong Zhang
    Year: 2021

 

  • Bushen-Tiansui Formula Improves Cognitive Functions in an Aβ1–42 Fibril-Infused Rat Model of Alzheimer’s Disease
    Authors: Chenxia Sheng, Panpan Xu, Xinyi Liu, Weijun Peng, Daxiong Xiang, Shilin Luo
    Year: 2020

 

  • Osteogenesis activity of isocoumarin a through the activation of the PI3K-Akt/Erk cascade-activated BMP/RUNX2 signaling pathway
    Authors: Not explicitly listed
    Year: 2019

 

  • Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson’s Disease
    Authors: Shilin Luo, Seong Su Kang, Zhi-Hao Wang, Xia Liu, Julia X Day, Zhiping Wu, Junmin Peng, Daxiong Xiang, Wolfdieter Springer, Keqiang Ye
    Year: 2019

 

  • Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile
    Authors: Not explicitly listed
    Year: 2018

 

Conclusion

Dr. Luo’s unwavering dedication to neurological research continues to shape the future of neuropharmacology. His innovative approach, combining traditional medicinal insights with modern scientific advancements, has the potential to revolutionize drug development for neurodegenerative diseases. As a mentor, researcher, and pioneer in his field, his contributions will leave a lasting impact on both academia and clinical medicine, offering hope for more effective treatments in the years to come.

 

Nawal Al-Subaie | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assist Prof Dr. Nawal Al-Subaie | Clinical Neuroscience | Best Researcher Award

Assist Prof Dr. Nawal Al-Subaie,  Princess Noura University, Saudi Arabia

Nawal Al Subaie is a dedicated Clinical Pharmacist with extensive experience in clinical and academic roles at esteemed institutions, including Prince Sultan Military Medical City (PSMMC) and Princess Noura University (PNU). She holds a PhD in Clinical Pharmacy from DMU, UK, and a Master’s in International Practice and Policy from UCL, London. With a career spanning leadership, clinical care, and education, she has made significant contributions to pharmacy practice, quality control, and chronic disease management. Her commitment to continuous learning is reflected in numerous specialized courses and symposiums, along with frequent contributions to global conferences.

 

profile

scholor

🎓 Educational Background

PhD in Clinical Pharmacy,DMU Leicester, United Kingdom.MSc in Clinical Pharmacy (International Practice and Policy)
,UCL School of Pharmacy, London, United Kingdom.Bachelor’s Degree in Hospital Pharmacy,King Saud University, Riyadh, Saudi Arabia.

💼 Working Experience

Deputy in Charge of Pharmacy Division.Family and Community Medicine.Lead Pharmacist. Wazarat Health Centre (WHC).Clinical Pharmacist,Chronic Disease Clinic, WHC.Clinical Instructor / Trainer,Continuous education for pharmacy students at King Saud University, Princess Noura University, Northern Border University.Quality Control Representative Pharmacy, WHC.Part-time Lecturer,Clinical Ocular Pharmacology, King Saud University.JCI Accreditation Awardee,Primary Care Team.In-Charge of Clinical Pharmacist Ambulatory Care Clinics, PSMMC, 2020–2022.Assistant Professor,Princess Noura University (PNU), May 2022 – Present.

🏫 Training Courses / Symposiums

2015 – 2019: PhD Student (Diabetes and Exercise)Pharmacy School, DMU, UK.2014: TOT Course Leicester, UK.2016: Phlebotomy Course Nottingham, UK.2016: First Aid CourseLeicester, UK.2022: ASHP Diabetes Management Certificate Course January – December 2022.

🌍 Conferences Attended & Contributions

2024: Attended the 4th Saudi Society of Clinical Pharmacist Annual International Conference (September).2024: Presented Poster at Dubai International Pharmaceuticals and Technologies Conference.2023: Oral Presentation at Neurology Conference, Dubai (March).2023: Judge, Pharmacy Research Day, PNU Research Center (May).2022: Attended First Saudi Society of Clinical Pharmacist Annual International Conference (September)(and many more from 2000 to 2024)

🤲 Voluntary Work

University orientation for new students, DMU. Diabetes Awareness Day, in collaboration with Diabetes UK. Trained students at DMU on ELISA and Randox machine for blood sample analysis. Assisted pharmacy students with projects and dissertations, DMU

🏅 Professional Memberships

Saudi Commission for Health Specialties (ID: 09-R-P-0295492)

📚 Publications

  1. Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review
    Authors: N. Alsubaie, H.M. Al-Kuraishy, A.I. Al-Gareeb, B. Alharbi, M. De Waard, …
    Year: 2022

 

  1. Discussing Pathologic Mechanisms of Diabetic Retinopathy & Therapeutic Potentials of Curcumin and β-glucogallin in the Management of Diabetic Retinopathy
    Authors: M. Rohilla, S. Bansal, A. Garg, S. Dhiman, S. Dhankhar, M. Saini, S. Chauhan, …
    Year: 2023

 

  1. The Potential Therapeutic Effect of Metformin in Type 2 Diabetic Patients with Severe COVID-19
    Authors: H.M. Al-Kuraishy, A.I. Al-Gareeb, A.A. El Kholy, E. El-Khateeb, A. Alexiou, …
    Year: 2023

 

  1. The Effects of a Combined Exercise Programme Aerobic and Resistance on Blood Glucose, Incretin, Metabolic and Inflammatory Mediators that Could Control the Diabetes and Improve …
    Author: N. Alsubaie
    Year: 2019

 

  1. Corrigendum to “Discussing Pathologic Mechanisms of Diabetic Retinopathy & Therapeutic Potentials of Curcumin and β-glucogallin in the Management of Diabetic Retinopathy”
    Authors: M. Rohilla, S. Bansal, A. Garg, S. Dhiman, S. Dhankhar, M. Saini, S. Chauhan, …
    Year: 2024

 

  1. Impact of Clinical Pharmacist Diabetes Clinic on the Improvement of Health Outcomes in Type 2 Diabetes Subjects
    Authors: N. AlSubaie, M. Alsallal, S. AlTwaijri, A. AlOtaibi, B. AlHarbi, M. AlEissa, …
    Year: 2022

 

  1. The Effects of a Combined Aerobic and Resistance Exercise Programme on Insulin Resistance Among Prediabetes Subjects
    Authors: B. Alharbi, N. Alsubaie, T.S. Sahota, M.J. Taylor
    Year: 2019

 

  1. The Effects of a Combined Exercise Programme (Aerobic and Resistance) on Blood Glucose and Incretin Hormone That Could Control the Diabetes in Type 2 Diabetes
    Authors: N. Alsubaie, B. Alharbi, T.S. Sahota, M.J. Taylor
    Year: 2019

 

  1. The Effects of a Combined Exercise Programme (Aerobic and Resistance) on Blood Glucose, and Incretin Hormone That Could Control the Diabetes in Type 2 Diabetes
    Authors: B.M. Alharbi, N.S. Alsubaie, T.S. Sahota, M.J. Taylor
    Year: 2019

 

  1. The Impact of Moderate Combination Exercise on HbA1c, IL-6, and TNF in Type 2 Diabetic and Non-diabetic Subjects: An Interventional Non-randomized Clinical Trial
    Authors: B. Alharbi, N. Alsubaie, T.S. Sahota, M.J. Taylor
    Year: 2019

 

 Conclusion

Dr. Al Subaie’s career showcases a deep commitment to enhancing patient care, advancing pharmaceutical education, and contributing to international health discussions. Her background in both hands-on clinical care and academic research equips her with a well-rounded perspective, making her a valuable asset in clinical and educational settings alike. She continues to make strides in diabetes management, chronic disease care, and pharmacy education, with her work recognized through multiple presentations, awards, and professional memberships.

 

 

Hamid khan | Molecular and Cellular Neuroscience | Young Scientist Award

Published on by Neuroscientists

Mr.Hamid khan | Molecular and Cellular Neuroscience | Young Scientist Award

Mr. Hamid khan Icahn School of Medicine at Mount Sinai, New York Pakistan

Hamid Khan is a dedicated researcher and educator who recently completed his PhD in Biotechnology, specializing in Human Molecular Genetics. His academic journey includes a strong foundation in biological sciences, evidenced by his educational background ranging from a BSc to a PhD, with a focus on genetic analysis of rare congenital disorders. His doctoral research has provided insights into the genetic basis of autism spectrum disorder (ASD) and oculocutaneous albinism, contributing significantly to the understanding of these conditions.

profile

scholar

🎓 Education

PhD in Biotechnology (Human Molecular Genetics)International Islamic University Islamabad, Pakistan & University of Toronto, Canada (2018-2024).MS/M.Phil in Biotechnology (Human Molecular Genetics)International Islamic University Islamabad, Pakistan (2016-2018).M.Sc in ZoologyHazara University Mansehra, KPK, Pakistan (2011-2013).B.Sc in Biological Science (Botany, Zoology, Chemistry)University of Peshawar, Pakistan (2008-2010).H.S.S.C Pre-Medical
Peshawar Board, Pakistan (2006-2008)S.S.C Science SubjectsPeshawar Board, Pakistan (2004-2006).B.Ed in Education
Sarhad University of Science & Information Technology (2014).CT Certified TeacherAllama Iqbal Open University (2016).

🔬 Research Experience

Researcher at Biomolecular Genetic Engineering Lab, International Islamic University Islamabad (4 years).Research Associate in Pak-US Science and Technology Cooperation Program (1 year).Researcher in MiND Laboratory, Campbell Family Mental Health Research Institute, Toronto, Canada (6 months)

💼 Work Experience

Visiting Lecturer at Department of Biological Sciences, IIUI (3 years).Lecturer at IQRA College of Technology, IIUI (2 years)

 

🛠️ Skills

Laboratory Skills: PCR, NGS data analysis, Microarray, Gene Cloning, Cell Culturing, etc.Computer Skills: Python, Sentieon, Verseq, Exomiser, Excel, PowerPoint, Word.

🏆 Awards

IRSIP Award from the Higher Education Commission (HEC) Pakistan.First position holder in PhD coursework.Selected as Research Associate in a Pak-US project.

🌍 Collaborations

Currently working with three international and several national collaborations.

📚 Publications

  1. Title: Biallelic variants identified in 36 Pakistani families and trios with autism spectrum disorder
    Authors: Hamid Khan, Ricardo Harripaul, Anna Mikhailov, Sumayah Herzi, …
    Year: 2024

 

  1. Title: Elucidating the clinical and genetic spectrum of inositol polyphosphate phosphatase INPP4A-related neurodevelopmental disorder
    Authors: Lettie E Rawlins, Reza Maroofian, Stuart J Cannon, Muhannad Daana, Mina Zamani, Shamsul Ghani, …
    Year: 2024

 

  1. Title: Nigella sativa extract abrogates traumatic brain injury-induced memory impairment in adult mice
    Authors: RU Khan, SM Jawad, MM Kiyani, SA Shah, S Bashir, Hamid Khan
    Year: 2024

 

  1. Title: Mutational spectrum associated with oculocutaneous albinism and Hermansky-Pudlak syndrome in nine Pakistani families
    Authors: J Khan, S Asif, S Ghani, Hamid Khan, MW Arshad, SA Khan, S Lin, EL Baple, …
    Year: 2024

 

  1. Title: An Update on Recent Advancement in Autism Spectrum Disorder Treatment Strategies
    Authors: Hamid Khan, M Uzair, H Riaz, B Khan, MI Shabbir
    Year: 2023

Conclusion

Hamid Khan’s profile illustrates a strong commitment to advancing the field of biotechnology through research and education. His focus on the genetic underpinnings of rare disorders positions him as a valuable contributor to both academic and clinical settings. With a proven track record of research publications and collaborative projects, he is poised to make significant impacts in the realm of human genetics and molecular biology. His dedication to teaching and nurturing student curiosity further underscores his potential as an educator and mentor. As he seeks new opportunities, his combination of technical expertise, research experience, and passion for education will undoubtedly enable him to excel and inspire in any dynamic academic or research environment.